Johnson and Johnson Innovation Logo

With COVID-19, we’ve seen our preparedness response tested, and the question remains, how can we be better prepared to protect some of the most vulnerable members of our communities, our babies and children, from future threats? Unfortunately, less innovation takes place in the pediatric space due barriers in the discovery and development environment, including, ethical dilemmas, and regulatory requirements.

How can innovators work to develop pediatric therapeutics, diagnostics, vaccines, and other technologies that may protect the smallest members of society during a pandemic? Join us as we sit with key thought leaders, innovators and game-changers in the pediatrics space to discuss what is being done to develop groundbreaking medical countermeasures that aim to prepare and protect pediatric populations from the health threats of today – and those imagined and unimagined of tomorrow.